疏血通与阿司匹林联合治疗进展型脑梗死疗效分析

摘要

目的 研究分析疏血通和阿司匹林联合用药对进展型脑梗死患者的治疗效果.方法 根据我院2011~2014年的82例进展型脑梗死患者来分析研究,将这些患者分组为对照组41例,观察组41例,观察组使用疏血通和大剂量阿司匹林联合治疗,对照组使用曲克芦丁与小剂量阿司匹林联合治疗.对两组患者治疗15天的效果进行比较分析.结果 观察组的临床有效率是92.68%,对照组的有效率是73.17%,P<0.05.两组患者的红细胞比容、血小板聚集率、血浆比黏度等均低于治疗前,P<0.05,观察组的血小板聚集率比对照组低,P<0.05.两组的凝血指标治疗前后无差异性.此次研究中没有出现不良反应病例.结论 进展型脑梗死患者在发病初期使用疏血通和大剂量阿司匹林的治疗方式效果突出,安全可靠,临床中应用效果好,应用价值高.%Objective To study the therapeutic effect of Shuxuetong analysis and aspirin for patients with progressive cerebral infarction. Methods82 cases of patients with progressive cerebral infarction in our hospital from 2011 to 2014 were selected to analysis and study, who were divided into observe group with 41 cases and control group with 41 cases, the observe group were treated by Shuxuetong and large dose of aspirin, the control group used Troxerutin and small dose of aspirin to treat. Compare and analysis of the therapeutic effect after 15 days.Results The clinical efficiency of the observation group was 92.68%, the effective rate of the control group was 73.17%, P<0.05. Hematocrit, platelet aggregation rate, the plasma viscosity in two groups were lower than those before treatment,P<0.05, the rate of platelet aggregation was lower than the control group,P<0.05. The indicator of blood coagulation had no difference before and after treatment. There was no adverse reactions in this research.Conclusion The therapeutic effect of Shuxuetong and large dose of aspirin in patients with progressive cerebral infarction in the early onset of treatment is prominent, safe and reliable, the clinical application effect is good, and with high application value.